China Approves Two More Home-Grown COVID-19 Antivirals

 
• By Dexter Jie Yan
endpoint of symptom resolution
time to symptom resolution or recovery a top pick for primary endpoint in COVID antiviral trials • Source: Shutterstock

More from China

More from Asia